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Alzheimer diseaseBackground and purpose: Alzheimer’s disease (AD) is a major cause of dementia in elderly affecting about
30% above the age of 85 years, while mild cognitive impairment (MCI) is the impairment in cognitive
functions with intact daily life activities which is described as the preclinical phase of AD.
Purpose: To evaluate the role of DWI and MRS in prediction of pre-Alzheimer’s patients and differentiat-
ing them from those with AD.
Patients and methods: This study included 37 patients (24 males and 13 females) with age ranged from 50
to 73 years (mean age = 61.6 years). They were divided into two main groups, the first group pre-
Alzheimer’s (MCI) included 24 patients, and the second group (AD) included 13 patients. All patients
underwent DWI and MRS using 1.5 T system.
Results: In our study, males were more commonly affected by the two diseases, the mean age was 61.6
years and memory dysfunction followed by depression was the most common clinical symptom.
Regarding DWI study, there were statistically higher ADC values in AD (0.97 and 0.94) than in MCI
(0.90 and 0.79) in the hippocampal and temporal regions respectively. The NAA/Cr ratio was significantly
higher in MCI (1.74 and 1.58) than in AD (1.41 and 1.05) in the hippocampal, temporal regions respec-
tively. Regarding mI/Cr ratio, it was significantly higher in AD (1.51 and 1.47) than in MCI (1.10 and
1.11). The Cho/Cr ratio also was significantly higher in AD (1.27 and 1.38) than in MCI (1.02 and 0.99)
in the same regions respectively. From the ROC curve analysis the NAA/Cr ratio was the most sensitive
and specific in both regions.
Conclusions: Mild cognitive impairment is a term used to describe the pre-Alzheimer’s stage. Later, most
of MCI patients develop Alzheimer’s dementia. The combination of DWI and MRS is promising tool for the
detection of early structural changes occurring in MCI patients before the full manifestation of dementia
syndrome starts to appear.
Clinical significance: DWI and MRS help in early prediction, follow-up, and treatment of patients with pre-
Alzheimer’s disease.
 2016 The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).1. Introduction
Most of the elderly individuals follow a mild course of a gradual
cognitive decline, typically in memory, but this degree of decline is
minor and does not compromise a person’s ability to function.
While fewer population go through life with virtually no cognitivedecline, these individuals are regarded as aging successfully. On
the other hand the cognitive decline in the elderly is due to the
pathological aging of the brain resulting in dementia, and its most
common type, Alzheimer’s disease [1].
Cognitive impairment (MCI) is defined as cognitive aging but
without dementia. It usually starts in middle age and accelerates
in old age. Regarding the incidence rates of MCI, it was about
31.9% in people older than 60 years with the incidence of the
MCI has shown to be increased every 5 years. Also, MCI is consid-
ered as preclinical dementia, and the prevention of it is important
clinically [2].cl Med
2 A.A. Sultan et al. / The Egyptian Journal of Radiology and Nuclear Medicine xxx (2016) xxx–xxxNowadays, the challenge for neuroradiologists is the early
diagnosis of this disorder in the pre-dementia state. This early
diagnosis would identify who are targeted by treatment and close
follow-up, trying to prevent the more neurological deterioration.
Although the mild cognitive impairment (MCI) has been consid-
ered as an intermediate step between the normal state and Alzhei-
mer’s disease (AD), not all MCI patients develop AD at the similar
rate and even some patients never convert to AD [3].
Alzheimer’s disease (AD) accounts for 50–70% of all dementia
cases in elderly population, and age is a main risk factor as the dis-
ease affects about 8% of the elderly above 65 years and 30% above
the age of 85 years. At the time of clinical presentation of demen-
tia, irreversible brain damage is already present, and this makes
the diagnosis of AD at early stages of the disease an urgent prereq-
uisite [4].
More studies tried to assess the structural and functional abnor-
malities of the gray and white matter occurring in Alzheimer’s
dementia, and to detect whether the multimodal MRI evaluation
can provide the sufficient information about how to differentiate
between AD and the other types of dementia [5].
The main advantage of DWI is its ability to observe minor
changes occurring at the microscopic level. The cellular micro-
scopic barriers can normally restrict the Brownian motion of the
water molecules within the tissue. But after breakdown of these
structures, measureable difference in the diffusion of water mole-
cules is observed by DWI and several studies suggest they even
proceed the macroscopic atrophy [6].
MR spectroscopy is a non-invasive technique that allows the
detection of naturally occurring metabolites in the human brain.
These metabolites can detect structural alteration and biochemical
abnormalities in the brain of demented subjects and may help in
the differential diagnosis and early detection, monitoring disease
progression, and evaluation of therapy [7].
One common finding that was reported in the MRS changes as
associated with AD in the recent literatures is a decrease in the
NAA and its ratio to the creatine. Multiple observations suggested
that disruption of mitochondrial energy and metabolism leads to
reversible drop in the NAA concentration [8].
On the other hand the myo-inositol is a cyclic sugar alcohol
which is thought to be as a glial cell marker. In AD, a decreased
NAA combined with an increase in mI is thought to reflect the
pathological neuronal loss combined with the replacement
through gliosis [9].
Creatine (Cr) is the marker of energy metabolism via the Cr
kinase reaction generating ATP. In literatures, in AD the increase
in the mI concentration, as well as its ratio to the creatine is sug-
gested [10].
The high choline level as an MRS marker in AD patients may be
a consequence of membrane phosphatidyl choline catabolism pro-
duced to provide free choline for the chronically deficient acetyl-
choline production in the [11].2. Patients and methods
This study was conducted on patients with cognitive impair-
ment and dementia admitted to neurology department in Man-
soura University Hospital. It included 37 patients (24 males and
13 females), and the age ranged from 50 years up to 73 years.
The mean age was 61.6 years.
Clinically, the patients suffered from memory disorders by dif-
ferent degrees. While, depression, anxiety and behavioral changes
are the most clinical symptoms.
All patients underwent scanning with 1.5 T MRI systems Signa
HDe GE Healthcare Milwaukee Wis Medical System and/or Sie-
mens Magnetom Symphony Maestro Class, Syngo MR 2002BPlease cite this article in press as: Sultan AA et al. Role of DWI and MRS in diag
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coil was used for radiofrequency transmission and reception of the
MR signal and restraining foam pads were used to minimize head
motion. A scout sequence was run on each subject to help in slice
positioning, and then T1-weighted (T1W) and T2-weighted (T2W)
image sets were acquired in the axial, sagittal and coronal planes.
The T1W sequence was time–to-repetition ‘‘TR” = 500 ms, field of
view = 4 cm, matrix = 256  256 slices, acquisition time = 9:47
min. The T2W sequence was in axial, sagittal and coronal planes
with fast spin echo (FSE) multiplanar sequence with flow compen-
sation (TR = 3530 ms, TE = 81 and 70 ms, flip angle = 90, slice thick-
ness 5 mm, field of view = 24 cm, matrix = 256  160 slices,
acquisition time = 10:35 min).
Diffusion weighted echo planar images were acquired in the
axial plane (TR = 3200 ms, TE = 94 ms, FOV = 230 mm  230 mm,
20 slices, slice thickness 5 mm with 1.5 mm gap, matrix
size = 128 m  128 mm).
The apparent diffusion coefficient (ADC) was obtained for the
hippocampal, temporal, parietal, and frontal regions by 5 mm-
sized manually defined roi at the regions of interest.
All subjects underwent multi-voxel 1H-MR spectroscopy. All
MR spectroscopic examinations were performed by using
multi-voxel MR spectroscopy package. T1-weighted images in
the sagittal and coronal planes were obtained for localizing the
1MR spectroscopy voxels. 1MR spectroscopy voxels were placed
over the hippocampus, temporal and parietal areas. A time-to-
echo (TE) of 144 ms and TE of 35 ms was chosen to quantify the
different metabolites (NAA, mI, Cr and Cho). The NAA/Cr, mI/Cr
and Cho/Cr ratios were then determined for the hippocampus,
temporal and parietal areas.
Water suppression of the dominant water signal by CHESS tech-
nique, outer volume fat suppression as well as magnetic shimming
were performed automatically for all patients at the beginning of
MRS examination. Curve fitting was done automatically for all
obtained spectra. Post processing of the spectroscopic data con-
sisted of frequency shift and phase and linear baseline corrections
after Fourier transformation. These processes were automatic.3. Statistical methods
Data were tabulated, coded and then analyzed using the com-
puter program SPSS (Statistical package for social science) version
17.0 to obtain the following:
Descriptive data:
Descriptive statistics were calculated in the form of the
following:
1. Mean.
2. Standard deviation (±SD).
Analytical statistics:
In the statistical comparison between the different groups, the
significance of difference was tested using one of the following
tests:-
1- ANOVA (analysis of variance):- Used to compare between
more than two groups of numerical (parametric) data.
2- Inter-group comparison of categorical data was performed
by using chi square test (X2-value).
The sensitivity and specificity of ADC, mI/Cr, Ch/Cr and NAA/Cr
to differentiate between MCI and AD were examined at different
cutoff points using reciprocal operative curve (ROC) curve analysis
to determine the best cutoff point as well as the diagnostic power
of each test. A P value <0.05 was considered statistically significant.nosis of Alzheimer’s and pre-Alzheimer’s disease. Egypt J Radiol Nucl Med
Table 2
The differences in the MRS changes between MCI and AD.
Region of interest AD MCI P value
A-NAA/Cr
1-Hippocampus 1.41 ± 0.21 1.74 ± 0.21 <0.0001
2-Temporal 1.05 ± 0.15 1.58 ± 0.03 <0.0001
3-Parietal 1.79 ± 0.08 1.59 ± 0.04 <0.0001
B-mI/Cr
1-Hippocampus 1.51 ± 0.15 1.10 ± 0.17 <0.001
2-Temporal 1.47 ± 0.13 1.11 ± 0.24 <0.001
3-Parietal 1.51 ± 0.13 1.14 ± 0.14 <0.001
C-Ch/ Cr
1-Hippocampus 1.27 ± 0.8 1.02 ± 0.12 <0.001
2-Temporal 1.38 ± 0.17 0.99 ± 0.14 <0.001
3-Parietal 1.36 ± 0.08 1.02 ± 0.11 <0.001
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Our study included 37 patients, and they were divided accord-
ing to the clinical examination followed by DWI and MRS into two
main groups: the first group 24 patients with MCI and the second
group 13 patients with Alzheimer’s disease. The mean age of Alz-
heimer’s disease (63.77 ± 5.99 years) is higher than that of MCI
patients (57.78 ± 5.15 years). Also males were more commonly
affected by the two diseases.
Clinically, memory disorders by different degrees are present in
all the patients. While depression is the most common symptom, it
was present in 41.6% of the patients included (suffering from both
diseases). Anxiety affected 25% while behavioral changes affected
41.6% of the patients (see Tables 1 and 2).
It shows that AD patients (0.97, 0.94, 0.89, 0.92 and 0.83) had
higher ADC value than MCI patients (0.9, 0.79, 0.82, 0.76 and 0.8)
in the hippocampus, temporal, parietal, occipital and frontal
regions with statistically significant differences.
As regards the MRS changes, in this study the NAA/Cr ratio was
significantly higher in MCI patients (1.74, 1.58, and 1.59) than in
AD patients (1.4, 1.05 and 1.79) in the hippocampal, temporal
and parietal regions respectively. The mI/Cr ratio was significantly
higher in AD patients (1.51, 1.47 and 1.51) than in MCI patients
(1.1, 1.11 and 1.14) in the same regions, while the Cho/Cr ratio
was significantly higher in AD patients than in MCI patients in
the same regions.5. Discussion
Alzheimer’s disease is the most common neurodegenerative
diseases associated with aging and accounting for 60–70% of age-
related dementia cases. In 2000, approximately 25 million people
worldwide over the age of 60 were diagnosed with dementia; also
this number is expected to reach over 80 million by 2040 and ear-
lier diagnosis of AD is widely considered an important research
goal for researchers. MCI is frequently considered the prodromal
stage of AD, to the extent that MCI has been referred to as early-
stage of AD (or the pre-Alzheimer’s stage), and clinical manifesta-
tions of AD are now subdivided into the stage of MCI and the
subsequent stage of AD dementia [12].
In the present study, the mean age of MCI patients was
57.78 ± 5.15 years, and that of AD was 63.77 ± 5.99, and this was
in agreement with Katz et al. [13]. They reported that, the inci-
dence of dementia especially AD increases exponentially with
age, and the highest incidence of the disease was between 60
and 80 years. The mean age of AD was higher than that of MCI,
as the MCI represents the pre-dementia/pre-Alzheimer stage in
most of cases. This was in agreement with Olazarán et al. [14]
who studied 176 patients and they found 46.0% had MCI, and
10.2% had dementia at baseline. But after 1 year follow-up, 8 ofTable 1
The differences in the ADC value between MCI patients and AD.
Region of interest MC
ADC HP Mean 0.9
±SD 0.04
ADC T Mean 0.7
±SD 0.06
ADC F Mean 0.8
±SD 0.04
ADC P Mean 0.7
±SD 0.04
ADC OCC Mean 0.8
±SD 0.02
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dementia.
Regarding the sex prevalence, in the current study, the MCI
patients were 24, 16 males (66.6%) and 8 females (33.3%). The
AD patients were 13, 8 males (61.5%) and 5 females (38.5%). The
reports of the association between the gender of the patients and
MCI and/or dementia have been controversial. A population-
based prospective study was conducted by Petersen et al. [15]
found that the incidence of MCI was higher in men than in women.
As regards age and sex in Alzheimer’s disease, the current study
was in agreement with Rizzi et al. [16] and they reported that in
the old ages, the incidence of AD is higher among males, while in
very old ages, usually above 85, women may have slightly greater
possibility to develop dementia than men. Another study was car-
ried out by Mielke et al. [17] who reported higher incidence of AD
in males than in females until age 78, after which females showed
higher incidence than males.
As regards the clinical presentation of our patients, all of them
were suffering from memory dysfunction in different stages, and
this was in agreement with Grinberg et al. [18] who reported that,
for the diagnosis of dementia, the first complaint is usually the cog-
nitive complaint (memory dysfunction), while depression was the
second common symptom. These findings were in agreement with
Becker et al. [19] who reported that depression is a major symptom
in the patients suffering from MCI/dementia. Depression and cog-
nitive impairment/dementia usually co-exist and this makes it
challenging to determine whether the depression is within the
causal pathway leading to dementia or it is a consequence of the
disease. Both theories are supported in the literature, suggesting
that, there is no definitive answer for this question [20].
Regarding the diffusion MR imaging, in the current study, there
was increase in the ADC values in AD patients with statistically sig-
nificant differences when compared to the MCI patients in the hip-
pocampus, temporal, frontal, occipital and parietal regions.I AD P value
0 0.97 <0.0001
0.04
9 0.94 <0.0001
0.03
2 0.89 <0.0001
0.02
6 0.92 <0.0001
0.03
0 0.83 <0.0001
0.01
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Case 1  
Case 1. (A) Coronal FLAIR MR image showing mild bilateral hippocampal atrophy in mild cognitive impairment (MCI) case. (B–E) Showing ADC values in the hippocampal,
temporal, frontal, occipital and parietal regions respectively. (F) MRS changes in MCI case in the right hippocampal region in the form of decreased NAA, and minimal increase
in Cho and mI peaks.
4 A.A. Sultan et al. / The Egyptian Journal of Radiology and Nuclear Medicine xxx (2016) xxx–xxxZhang et al. [21] have studied 26 patients with MCI, 26 patients
with AD and 18 normal controls. They reported higher ADC values
from MCI patients compared to those of the normal control group
in the hippocampus. They explained that the increased water diffu-
sivity in AD and MCI occurs due to the disruption of the intracellu-
lar cytological skeletal framework due to neurofibrillary tangle
formation. Neuronal loss also accompanies neurofibrillary changes,
and the resultant expansion of the extracellular space would also
be expected to cause an elevation of ADC in MCI patients than in
normal control and in AD patients than those having MCI. Finally,
glial activation was also associated with amyloid plaque formation,
and that inflammatory process also resulted in expansion of thePlease cite this article in press as: Sultan AA et al. Role of DWI and MRS in diag
(2016), http://dx.doi.org/10.1016/j.ejrnm.2016.10.001extracellular spaces, and subsequently causing a higher ADC value
in both MCI and AD.
In the present study, higher ADC values were obtained also in
the temporal lobes and these results were in agreement with the
finding that the temporal lobe was one of the earliest structures
that were involved in development of pathological changes in
MCI and AD [21].
In addition, Reginold et al. used diffusion tensor imaging and
tractography to reconstruct white matter tracts based on restricted
diffusion of water molecules along myelinated axons and they
found that there is significant disruption of tracts that can be
detected as increased mean diffusivity (MD, degree of water diffu-nosis of Alzheimer’s and pre-Alzheimer’s disease. Egypt J Radiol Nucl Med
Case 2  
Case 2. (A) Coronal FLAIR MRI image showing significant brain and bilateral hippocampal atrophy in Alzheimer’s disease (AD) case. (B–E) Showing ADC values in the
hippocampal, temporal, frontal, occipital and parietal regions respectively (being higher than those in the MCI case in the different regions). (F) MRS changes in an AD case in
the right hippocampal region in the form of significant decreased NAA, and elevated mI and Cho peaks.
A.A. Sultan et al. / The Egyptian Journal of Radiology and Nuclear Medicine xxx (2016) xxx–xxx 5sion), increased axial diffusivity (AxD), increased radial diffusivity
(RD) or decreased fractional anisotropy (FA, directional diffusion)
in the temporal lobe white matter in patient with AD [22].
As regards MRS, the changes in neuronal activity during the pro-
gression of AD are associated with significant changes in the brain
metabolites. Brain metabolism can be measured accurately with
MRS. Using proton (1H)MRS, numerousmetabolites related to brain
functions can be detected, includingN-acetyl aspartate (NAA),myo-
inositol (mI), creatine (Cr), and choline (Cho). NAA is the only
metabolite present within neural cell body, axons and dendrites,
so it is considered to be the marker of neuronal viability and func-
tion, while mI on the other hand, has higher concentration within
the glial cells and thus it is often taken as a marker for gliosis [23].
In the present study, AD patients showed lower NAA/Cr
together with higher mI/Cr and Cho/Cr than patients with MCI.Please cite this article in press as: Sultan AA et al. Role of DWI and MRS in diag
(2016), http://dx.doi.org/10.1016/j.ejrnm.2016.10.001The differences were statistically significant in all the studied areas
(hippocampus, temporal and parietal). Our results are in agree-
ment with other 1H MRS studies which showed that, the glial acti-
vation marker mI or the ratio of mI to creatine (mI/Cr ratio) and the
membrane integrity marker Cho or the Cho: Cr ratio are elevated in
MCI and AD. The neuronal integrity marker NAA or the NAA:Cr
ratio tends to be decreased in patients with MCI and AD [7].
The decrease in the NAA level or NAA/Cr ratio was reported in
several other studies on patients with MCI whom latter on devel-
oped AD and in patients with probable AD. Increased mI has been
reported in patients with MCI and AD. In one 1HMRS study, Cho/Cr
ratios longitudinally increased in patients with MCI that pro-
gressed to AD [11].
Our results are in agreement with Graff-Radford and Kantarci
[24] who reported that AD patients had significant reduction innosis of Alzheimer’s and pre-Alzheimer’s disease. Egypt J Radiol Nucl Med
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and also when compared with MCI patients and this was the most
common 1H-MRS finding in AD. Reduced NAA/Cr ratios have been
also shown in the posterior cingulate gyrus, temporal, occipital,
parietal and frontal lobes.
These results are consistent with most of the in vitro studies
that were done on the postmortem brains of AD patients, and these
studies also showed that NAA reduction correlated with the sever-
ity of the neuro-pathologic findings, such as the pathological amy-
loid plaques, the neurofibrillary tangles, and the presence of the
apolipoprotein E genetic markers. Therefore, reduction in the
NAA levels may reflect either a loss of the neuronal cells or neu-
ronal function or even both of them [7]. Increased mI has also been
reported in several anatomic locations in AD, and this was an
indicative of the increased glial cell content in AD if compared to
MCI patients. Increased mI has been reported most frequently in
the posterior cingulate gyrus, temporal, parietal, frontal white mat-
ter and occipital lobes [10].
Finally, it should be mentioned that neuro-radiologists have
made a great effort since the initial use of MRI in AD imaging to
assess changes in brain anatomy, specifically the brain shrinkage
and regional changes in white matter. However these efforts
should be combined with DWI, tractography using diffusion tensor
imaging, MRS as well as the clinical and biochemical methods to
reach accurate diagnostic level [25,26] (see Cases 1 and 2).
Limitations of the study:
– Some degree of irritability of the elderly patients.
– Longtime of examination.
6. Conclusions
 Mild cognitive impairment (MCI) is a term used to describe
symptomatic patients who do not meet the criteria for
dementia.
 The majority of individuals with MCI develop dementia in the
near future.
 The multimodality MRI including DWI and MRS are promising
tools for the detection of micro- and macro-structural changes
occurring in brain, before the full manifestation of dementia
starts to appear. This early diagnosis allows better treatment
and follow-up of those patients.
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